Search Results
You Searched For:
3 Records
Serial No. 116-123 (House Hearing) - Unsustainable Drug Prices:. Testimony from the Ceos (Part II)
Congressional Hearings. General. Oversight and Reform. Thursday, October 1, 2020.
... SIXTEENTH CONGRESS SECOND SESSION OCTOBER 1, 2020 Serial No. 116-123 Printed for the use of the Committee on Oversight and Reform [GRAPHIC NOT AVAILABLE IN TIFF FORMAT] Available on: govinfo.gov, oversight.house.gov or docs.house.gov U.S. GOVERNMENT PUBLISHING OFFICE 41-983 PDF WASHINGTON : 2020 COMMITTEE ON OVERSIGHT AND REFORM CAROLYN B. ...
Serial No. 116-122 (House Hearing) - Unsustainable Drug Prices: Testimony from the Ceos (Part I)
Congressional Hearings. General. Oversight and Reform. Wednesday, September 30, 2020.
... SIXTEENTH CONGRESS SECOND SESSION SEPTEMBER 30, 2020 Serial No. 116-122 Printed for the use of the Committee on Oversight and Reform [GRAPHIC NOT AVAILABLE IN TIFF FORMAT] Available on: govinfo.gov, oversight.house.gov or docs.house.gov U.S. GOVERNMENT PUBLISHING OFFICE 41-982 PDF WASHINGTON : 2020 COMMITTEE ON OVERSIGHT AND REFORM CAROLYN B. ...
Serial No. 117-22 (House Hearing) - Unsustainable Drug Prices (Part III): Testimony from Abbvie Ceo Richard Gonzalez
Congressional Hearings. General. Oversight and Reform. Tuesday, May 18, 2021.
... ONE HUNDRED SEVENTEENTH CONGRESS FIRST SESSION MAY 18, 2021 Serial No. 117-22 Printed for the use of the Committee on Oversight and Reform [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] Available on: govinfo.gov, oversight.house.gov or docs.house.gov ______ U.S. GOVERNMENT PUBLISHING OFFICE 44-685 PDF WASHINGTON : 2021 COMMITTEE ON OVERSIGHT ...